Effects of green tea supplementation on serum concentrations of adiponectin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

References

• Abdi, A., et al., 2020. Effects of concurrent training on irisin and fibronectin type-III domain containing 5 (FNDC5) expression in visceral adipose tissue in type-2 diabetic rats. Archives of physiology and biochemistry, 21, 1–6.
   Google Scholar
• Achari, A.E., and Jain, S.K., 2017. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. International journal of molecular sciences, 18 (6). doi:10.3390/ijms18061321
   PubMed Web of Science ®Google Scholar
• Alipour, M., et al., 2018. The effects of catechins on related risk factors with type 2 diabetes: a review. Progress in nutrition, 20 (1), 12–20.
   Google Scholar
• Amani, R., et al., 2018. Vitamin D3 induced decrease in IL-17 and malondialdehyde, and increase in IL-10 and total antioxidant capacity levels in patients with irritable bowel syndrome. The Iranian journal of immunology, 15 (3), 186–196.
   PubMed Web of Science ®Google Scholar
• Asbaghi, O., et al., 2019. The effect of green tea on C-reactive protein and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Complementary therapies in medicine, 46, 210–216.
   PubMed Web of Science ®Google Scholar
• Awazawa, M., et al., Kadowaki, T., 2011. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell metabolism, 13 (4), 401–412.
   PubMed Web of Science ®Google Scholar
• Bagheri, R., et al., 2020a. Does green tea extract enhance the anti‐inflammatory effects of exercise on fat loss? British journal of clinical pharmacology, 86 (4), 753–762.
   PubMed Web of Science ®Google Scholar
• Bagheri, R., et al., 2020b. Effects of green tea extract supplementation and endurance training on irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged men. European journal of applied physiology, 120 (4), 915–923.
   PubMed Web of Science ®Google Scholar
• Bhaktha, G., et al., 2015. Relationship of caffeine with adiponectin and blood sugar levels in subjects with and without diabetes. Journal of clinical and diagnostic research, 9 (1), Bc01–03.
   PubMed Web of Science ®Google Scholar
• Brozek, J.L., et al.,; GRADE Working Group. 2009. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy, 64 (5), 669–677.
   PubMed Web of Science ®Google Scholar
• Cercato, L.M., et al., 2015. A systematic review of medicinal plants used for weight loss in Brazil: Is there potential for obesity treatment? Journal of ethnopharmacology, 176, 286–296.
   PubMed Web of Science ®Google Scholar
• Cho, N.H., et al., 2018. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, 138, 271–281.
   PubMed Web of Science ®Google Scholar
• Cho, S.Y., et al., 2007. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells . American journal of physiology. endocrinology and metabolism, 292 (4), E1166–E1172.
   PubMed Web of Science ®Google Scholar
• Dawling, S., et al., 2001. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer research, 61 (18), 6716–6722.
   PubMed Web of Science ®Google Scholar
• DerSimonian, R., and Kacker, R., 2007. Random-effects model for meta-analysis of clinical trials: an update. Contemporary clinical trials, 28 (2), 105–114.
   PubMed Web of Science ®Google Scholar
• Dostal, A.M., et al., 2016. Green tea extract and catechol-o-methyltransferase genotype modify fasting serum insulin and plasma adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women. The journal of nutrition, 146 (1), 38–45.
   PubMed Web of Science ®Google Scholar
• Fang, H., and Judd, R.L., 2018. Adiponectin regulation and function. Comprehensive Physiology, 8 (3), 1031–1063.
   PubMed Web of Science ®Google Scholar
• Ferreira, M.A., et al., 2016. Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review. Obesity reviews, 17 (12), 1316–1328.
   PubMed Web of Science ®Google Scholar
• Fisman, E.Z., and Tenenbaum, A., 2014. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovascular diabetology, 13, 103.
   PubMed Web of Science ®Google Scholar
• Ghoshal, K., and Bhattacharyya, M., 2015. Adiponectin: probe of the molecular paradigm associating diabetes and obesity. World journal of diabetes, 6 (1), 151–166.
   PubMed Web of Science ®Google Scholar
• Haghighatdoost, F., Nobakht, M.G.B.F., and Hariri, M., 2017. Effect of green tea on plasma adiponectin levels: a systematic review and meta-analysis of randomized controlled clinical trials. Journal of the American college of nutrition., 36 (7), 541–548.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., and Green, S., 2008. Cochrane handbook for systematic reviews of interventions. Wiley Online Library.
   Google Scholar
• Hodgson, J.M., et al., 2006. Is reversal of endothelial dysfunction by tea related to flavonoid metabolism? British Journal of Nutrition, 95 (1), 14–17.
   PubMed Web of Science ®Google Scholar
• Hotta, K., et al., Matsuzawa, Y., 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, thrombosis, and vascular biology, 20 (6), 1595–1599.
   PubMed Web of Science ®Google Scholar
• Hozo, S.P., Djulbegovic, B., and Hozo, I., 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology, 5 (1), 13.
   PubMedGoogle Scholar
• Hsu, C.H., et al., 2011. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Alternative medicine review: a journal of clinical therapeutic, 16 (2), 157–163.
   PubMed Web of Science ®Google Scholar
• Hursel, R., Viechtbauer, W., and Westerterp-Plantenga, M.S., 2009. The effects of green tea on weight loss and weight maintenance: a meta-analysis. International journal of obesity, 33 (9), 956–961.
   PubMed Web of Science ®Google Scholar
• Jalali, M.T., Mohammadtaghvaei, N., and Larky, D.A., 2016. Investigating the effects of Capparis Spinosa on hepatic gluconeogenesis and lipid content in streptozotocin-induced diabetic rats. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 84, 1243–1248.
   PubMed Web of Science ®Google Scholar
• Kadowaki, T., et al., 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. The journal of clinical investigation, 116 (7), 1784–1792.
   PubMed Web of Science ®Google Scholar
• Kooti, W., et al., 2016. The role of medicinal plants in the treatment of diabetes: a systematic review. Electronic physician, 8 (1), 1832–1842.
   PubMedGoogle Scholar
• Krul, C., et al., 2001. Antimutagenic activity of green tea and black tea extracts studied in a dynamic in vitro gastrointestinal model. Mutation research., 474 (1-2), 71–85.
   PubMed Web of Science ®Google Scholar
• Kumada, M., et al., Matsuzawa, Y., 2003. Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, thrombosis, and vascular biology, 23 (1), 85–89.
   PubMed Web of Science ®Google Scholar
• Liu, C.Y., et al., 2014. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. Plos one, 9 (3), e91163.
   PubMed Web of Science ®Google Scholar
• Liu, K., et al., 2013. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. The American journal of clinical nutrition, 98 (2), 340–348.
   PubMed Web of Science ®Google Scholar
• Mirzaei, K., et al., 2009. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; A double-blind, placebo-controlled clinical trial study. Daru-journal of pharmaceutical sciences, 17, 38–44.
   Web of Science ®Google Scholar
• Mohammadi, S., et al., Jafari, N., 2010. The effects of green tea extract on serum adiponectin concentration and insulin resistance in patients with type 2 diabetes mellitus. Journal of Zanjan university of medical sciences and health services, 18 (70), 44–57.
   Google Scholar
• Moher, D., et al., 2010. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International journal of surgery, 8 (5), 336–341.
   Google Scholar
• Nagao, T., et al., Yamamoto, K., 2009. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (silver spring, md.).), 17 (2), 310–317.
   PubMed Web of Science ®Google Scholar
• Ouchi, N., et al., Matsuzawa, Y., 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100 (25), 2473–2476.
   PubMed Web of Science ®Google Scholar
• Salehi-Abargouei, A., Izadi, V., and Azadbakht, L., 2015. The effect of low calorie diet on adiponectin concentration: a systematic review and meta-analysis. Hormone and metabolic research, 47 (08), 549–555.
   PubMedGoogle Scholar
• Samarghandian, S., Azimi-Nezhad, M., and Farkhondeh, T., 2017. Catechin treatment ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Dose-response, 15 (1), 155932581769115.
   Web of Science ®Google Scholar
• Sang, S., et al., 2011. The chemistry and biotransformation of tea constituents. Pharmacological research, 64 (2), 87–99.
   PubMed Web of Science ®Google Scholar
• Schulze, M.B., et al., 2004. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes care, 27 (7), 1680–1687.
   PubMed Web of Science ®Google Scholar
• Shimada, M., et al., 2007. Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats. Bioscience, biotechnology, and biochemistry, 71 (8), 2079–2082.
   PubMed Web of Science ®Google Scholar
• Silva, T.E., Colombo, G., and Schiavon, L.L., 2014. Adiponectin: A multitasking player in the field of liver diseases. Diabetes & metabolism, 40 (2), 95–107.
   PubMed Web of Science ®Google Scholar
• Sung, H.Y., et al., Song, D.K., 2010. Role of (-)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes. Naunyn-Schmiedeberg's archives of pharmacology, 382 (4), 303–310.
   PubMed Web of Science ®Google Scholar
• Wellen, K.E., and Hotamisligil, G.S., 2005. Inflammation, stress, and diabetes. The journal of clinical investigation, 115 (5), 1111–1119.
   PubMed Web of Science ®Google Scholar
• Weyer, C., et al., 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of clinical endocrinology and metabolism., 86 (5), 1930–1935.
   PubMed Web of Science ®Google Scholar
• Yatagai, T., et al., Ishibashi, S., 2003. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism: clinical and experimental, 52 (10), 1274–1278.
   PubMed Web of Science ®Google Scholar